FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
01/08/2025
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Tipo de processo
Eventos registrados
Atualização mais recente
Classificação
Tipo de marca
Classes Nice
Data de depósito
Data de registro
Data de expiração
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
Última transação
Escritório responsável
Código da situação
Cadastro oficial
Código do desenho
Tipo de titular
Localização do titular
Examinador
Localização atual
Titulares
Representantes
Leo M. Loughlin Rothwell, Figg, Ernst & Manbeck, PC
Classes Nice
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemical, biochemical and biotechnological reagents for industrial and scientific purposes and laboratory analysis, other than in vivo use and other than for medical or veterinary purposes; Chemical, biochemical and biotechnological substances for industrial and scientific purposes and laboratory analysis, other than in vivo use and other than for medical or veterinary purposes; Biochemicals for scientific and research use, namely, for sample preparation, modification and manipulation of cells and for labeling, isolation, purification, amplification and analysis of natural and synthetic biopolymers in the nature of nucleotides, buffer substances such as salts and proteins for industrial use, macromolecules and biologically active substances, none of the foregoing for medical or veterinary use; biochemicals, namely, small molecular chemicals for scientific or research use; laboratory chemicals, namely, small molecular chemicals used for the detection of nucleic acids in cell and tissue analysis for in vitro diagnostic use; chemicals and biochemical preparations used in industry, in particular, chemical and biochemical substances for molecular biological, biochemical and immunological laboratory testing and analysis, other than for medical or veterinary purposes; kits comprising biochemical reagents for scientific and research use, namely, for sample preparation, modification and manipulation of samples and cells and for labeling, separation, isolation, purification, especially amplification and analysis of natural and synthetic biopolymers, in particular, nucleic acids for laboratory use, oligonucleotides, proteins for industrial use, macromolecules and biologically active substances, none of the foregoing for medical or veterinary use; kits for multiplex polymerase chain reaction (PCR) tests comprised of DNA primers for amplifying DNA and RNA loci
Classe 5
Pharmaceutical medical preparations for treating infections; veterinary medical products, namely, vaccines; medical products for medical healthcare purposes, namely, reagents for medical use; diagnostic preparations for medical and veterinary purposes; diagnostic agents for medical and veterinary purposes, namely, diagnostic agents for medical and veterinary in-vitro diagnostics; diagnostic agents for medical and veterinary purposes, namely, biological diagnostic agents for testing diseases in cattle, pigs, and other animals; kits comprised of reagents for medical use, of antisense oligonucleotides being pharmaceutical preparations of monoclonal antibodies for use in disease testing, and of in-vitro diagnostic reagents and diagnostic control reagents all for medical purposes, sold as a unit for medical purposes; diagnostic test kits comprised of testing equipment in the nature of biomolecules, namely, antisense oligonucleotides being pharmaceutical preparations, primers in the nature of nucleic acid sequences and probes in the nature of single stranded sequences for DNA and RNA biomarker testing and DNA and RNA infectious disease testing for medical, veterinary, and dental purposes; products for medical and veterinary medical purposes, namely, diagnostic preparations for sample preparation, for modification and manipulation of cells and for labelling, for separation, for isolation, for purification, for amplification and for analysis of natural and synthetic biopolymers, in the nature of nucleic acids, oligonucleotides, proteins, macromolecules and biologically active substances all being diagnostic medical preparations; chemical, biochemical and biotechnological products, namely, reagents for medical use, for sample preparation, and for modification and manipulation of cells, all for medical use; in vitro diagnostic preparations for medical purposes; diagnostic disease testing kits comprised of medical diagnostic reagents; buffers for medical and veterinary purposes, namely, extraction buffers; diagnostic disease testing kits comprised of chemical reagents for medical use, antisense oligonucleotides being pharmaceutical preparations, nucleotides being pharmaceutical preparations, extraction buffers, in-vitro diagnostic preparations, and diagnostic control reagents, all for medical and veterinary use, sold as a unit for medical and veterinary use
Histórico de despachos e eventos da marca no USPTO.
31 publicações encontradas
FINAL DECISION TRANSACTION PROCESSED BY IB
01/08/2025
FINAL DISPOSITION NOTICE SENT TO IB
11/07/2025
FINAL DISPOSITION PROCESSED
11/07/2025
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
14/04/2025
NOTICE OF REGISTRATION CONFIRMATION EMAILED
14/01/2025
REGISTERED-PRINCIPAL REGISTER
14/01/2025
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
17/09/2024
PUBLISHED FOR OPPOSITION
17/09/2024
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
28/08/2024
APPROVED FOR PUB - PRINCIPAL REGISTER
09/08/2024
TEAS/EMAIL CORRESPONDENCE ENTERED
05/07/2024
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/07/2024
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/07/2024
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
18/03/2024
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
28/02/2024
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
28/02/2024
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/01/2024
NON-FINAL ACTION E-MAILED
09/01/2024
NON-FINAL ACTION WRITTEN
09/01/2024
TEAS/EMAIL CORRESPONDENCE ENTERED
06/12/2023
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/12/2023
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/12/2023
REFUSAL PROCESSED BY IB
26/06/2023
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
06/06/2023
REFUSAL PROCESSED BY MPU
06/06/2023
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
09/04/2023
NON-FINAL ACTION WRITTEN
08/04/2023
ASSIGNED TO EXAMINER
01/04/2023
APPLICATION FILING RECEIPT MAILED
27/09/2022
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
23/09/2022
SN ASSIGNED FOR SECT 66A APPL FROM IB
22/09/2022
Proteção contínua da sua marca
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.